| Report Date | |
| Manager | |
| Fund Name | |
| Strategy | |
| Latest Return Date | |
| Latest Return | |
| Latest 6 Months | |
| Latest 12 Months | |
| Latest 24 Months (pa) | |
| Annualised Since Inception | |
| Inception Date | |
| FUM (millions) | |
| Fund Overview | The Fund's discretionary investment strategy commences with a macro view of the economy and direction to establish the portfolio's desired market exposure. Following this detailed sector and company research is gathered from knowledge of the individual stocks in the Fund's universe, with widespread use of broker research. Company visits, presentations and discussions with management at CEO and CFO level are used wherever possible to assess management quality across a range of criteria. Detailed analysis of company valuations using financial statements and forecasts, particularly focusing on free cash flow, is conducted. Technical analysis is used to validate the Manager's fundamental research and valuations and to manage market timing. A significant portion of the Fund's overall performance can be attributed to the attention and importance given to the macro economic outlook and the ability and willingness to adjust the Fund's market risk. |
| Manager Comments | The Fund returned -2.84% in December, with health care and information technology stocks reversing the gains from last month. Positive contributors during the month included Lifestyle Communities, Rio Tinto, Magellan, Aerometrex and Charter Hall. Key detractors included SPI Futures, Paradigm, Goodman Group, EML Payments and Ecofibre. The Fund's net equity market exposure was held steady at 74.2% (83.6% long and 9.4% short), with the key changes being a new position in Aerometrex, increased weightings in BHP, Commonwealth Bank, CSL and Rio Tinto, partially offset by the sale of Paradigm, Ecofibre and Clover and four new short positions. |
| More Information |